ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(2), P. 843 - 884
Published: Jan. 4, 2023
Immunotherapy
continues
to
be
in
the
spotlight
of
oncology
therapy
research
past
few
years
and
has
been
proven
a
promising
option
modulate
one's
innate
adaptive
immune
systems
for
cancer
treatment.
However,
poor
delivery
efficiency
agents,
potential
off-target
toxicity,
nonimmunogenic
tumors
significantly
limit
its
effectiveness
extensive
application.
Recently,
emerging
biomaterial-based
drug
carriers,
including
but
not
limited
cells
bacteria,
are
expected
candidates
break
dilemma
immunotherapy,
with
their
excellent
natures
intrinsic
tumor
tropism
immunomodulatory
activity.
More
than
that,
tiny
vesicles
physiological
components
derived
from
them
have
similar
functions
source
due
inheritance
various
surface
signal
molecules
proteins.
Herein,
we
presented
representative
examples
about
latest
advances
employed
cells,
derivatives.
Simultaneously,
opportunities
challenges
bacteria-based
carriers
discussed
provide
reference
future
application
immunotherapy.
Exploration,
Journal Year:
2023,
Volume and Issue:
3(1)
Published: Feb. 1, 2023
Bacterial
infection
has
become
one
of
the
leading
causes
death
worldwide,
particularly
in
low-income
countries.
Despite
fact
that
antibiotics
have
provided
successful
management
bacterial
infections,
long-term
overconsumption
and
abuse
contributed
to
emergence
multidrug
resistant
bacteria.
To
address
this
challenge,
nanomaterials
with
intrinsic
antibacterial
properties
or
serve
as
drug
carriers
been
substantially
developed
an
alternative
fight
against
infection.
Systematically
deeply
understanding
mechanisms
is
extremely
important
for
designing
new
therapeutics.
Recently,
nanomaterials-mediated
targeted
bacteria
depletion
either
a
passive
active
manner
most
promising
approaches
treatment
by
increasing
local
concentration
around
cells
enhance
inhibitory
activity
reduce
side
effects.
Passive
targeting
approach
widely
explored
searching
nanomaterial-based
alternatives
antibiotics,
while
strategy
relies
on
biomimetic
biomolecular
surface
feature
can
selectively
recognize
In
review
article,
we
summarize
recent
developments
field
therapy
based
nanomaterials,
which
will
promote
more
innovative
thinking
focusing
multidrug-resistant
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Sept. 1, 2022
Abstract
Bacteria
can
bypass
the
blood-brain
barrier
(BBB),
suggesting
possibility
of
employment
bacteria
for
combating
central
nervous
system
diseases.
Herein,
we
develop
a
bacteria-based
drug
delivery
glioblastoma
(GBM)
photothermal
immunotherapy.
The
system,
which
name
as
‘Trojan
bacteria’,
consists
loaded
with
glucose
polymer
and
photosensitive
ICG
silicon-nanoparticles.
In
an
orthotopic
GBM
mouse
model,
demonstrate
that
intravenously
injected
BBB,
targeting
penetrating
tissues.
Upon
808
nm-laser
irradiation,
effects
produced
by
allow
destruction
bacterial
cells
adjacent
tumour
cells.
Furthermore,
debris
well
tumour-associated
antigens
promote
antitumor
immune
responses
prolong
survival
GBM-bearing
mice.
Moreover,
residual
are
effectively
eliminated
from
body,
supporting
potential
therapeutic
use
this
system.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: March 23, 2023
Abstract
Micro-nano
biorobots
based
on
bacteria
have
demonstrated
great
potential
for
tumor
diagnosis
and
treatment.
The
bacterial
gene
expression
drug
release
should
be
spatiotemporally
controlled
to
avoid
in
healthy
tissues
undesired
toxicity.
Herein,
we
describe
an
alternating
magnetic
field-manipulated
tumor-homing
developed
by
genetically
modifying
engineered
Escherichia
coli
with
Fe
3
O
4
@lipid
nanocomposites.
After
accumulating
orthotopic
colon
tumors
female
mice,
the
paramagnetic
nanoparticles
enable
receive
convert
signals
into
heat,
thereby
initiating
of
lysis
proteins
under
control
a
heat-sensitive
promoter.
then
lyse,
releasing
its
anti-CD47
nanobody
cargo,
that
is
pre-expressed
within
bacteria.
robust
immunogenicity
lysate
cooperates
activate
both
innate
adaptive
immune
responses,
generating
antitumor
effects
against
not
only
but
also
distal
mice.
magnetically
constant
field-controlled
motion
enhanced
targeting
increased
therapeutic
efficacy.
Thus,
behavior
can
manipulated
vivo
field,
achieving
tumor-specific
CD47
blockage
precision
immunotherapy.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(23)
Published: March 13, 2023
Photodynamic
therapy
(PDT)
has
become
a
promising
cancer
treatment
approach
with
superior
advantages.
However,
it
remains
grand
challenge
to
develop
tumor
microenvironment
(TME)-responsive
photosensitizers
(PSs)
for
tumor-targeting
precise
PDT.
Herein,
the
coupling
Lactobacillus
acidophilus
(LA)
probiotics
2D
CoCuMo
layered-double-hydroxide
(LDH)
nanosheets
(LA&LDH)
is
reported
as
TME-responsive
platform
NIR-II
The
CoCuMo-LDH
loaded
on
LA
can
be
transformed
from
crystalline
into
amorphous
through
etching
by
LA-metabolite-enabled
low
pH
and
overexpressed
glutathione.
TME-induced
in
situ
amorphization
of
boost
its
photodynamic
activity
singlet
oxygen
(1
O2
)
generation
under
1270
nm
laser
irradiation
relative
1
quantum
yield
1.06,
which
highest
among
previously
NIR-excited
PSs.
In
vitro
vivo
assays
prove
that
LA&LDH
effectively
achieve
complete
cell
apoptosis
eradication
irradiation.
This
study
proves
used
highly
efficient
Angewandte Chemie International Edition,
Journal Year:
2022,
Volume and Issue:
61(27)
Published: April 11, 2022
An
approach
of
decorating
bacteria
with
triple
immune
nanoactivators
is
reported
to
develop
tumor-resident
living
immunotherapeutics.
Under
cytocompatible
conditions,
tumor-specific
antigens
and
checkpoint
blocking
antibodies
are
simultaneously
conjugated
onto
bacterial
surface
then
polydopamine
nanoparticles
formed
via
in
situ
dopamine
polymerization.
In
addition
serving
as
a
linker,
its
photothermal
effect
can
repolarize
tumor-associated
macrophages
pro-inflammatory
phenotype.
The
linked
promote
the
maturation
dendritic
cells
generate
responses,
while
anchored
block
checkpoints
activate
cytotoxic
T
lymphocytes.
Decorated
show
spatiotemporal
tumor
retention
proliferation-dependent
drug
release,
achieving
potent
antitumor
effects
two
antigen-overexpressing
models.
This
work
provides
versatile
platform
prepare
multimodal
long-acting
therapeutics
for
cancer
immunotherapy.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(4), P. 6118 - 6133
Published: March 28, 2022
Microrobots
driven
by
multiple
propelling
forces
hold
great
potential
for
noninvasively
targeted
delivery
in
the
physiologic
environment.
However,
remotely
collective
perception
and
precise
a
low
Reynold's
number
bioenvironment
remain
major
challenges
of
microrobots
to
achieve
desired
therapeutic
effects
vivo.
Here,
we
reported
biohybrid
microrobot
that
integrated
with
magnetic,
thermal,
hypoxia
sensitivities
an
internal
fluorescent
protein
as
dual
reporter
thermal
positioning
signals
cancer
treatment.
There
were
three
key
elements
microrobotic
system,
including
magnetic
nanoparticle
(MNP)-loaded
probiotic
Escherichia
coli
Nissle1917
(EcN@MNP)
spatially
perception,
thermal-logic
circuit
engineered
into
bacteria
control
biosynthesis
mCherry
temperature
reporter,
NDH-2
enzyme
encoded
EcN
enhanced
anticancer
therapy.
According
fluorescent-protein-based
imaging
feedback,
showed
good
sensitivity
active
targeting
ability
tumor
area
manner
under
field.
The
cell
apoptosis
was
efficiently
triggered
vitro
vivo
hybrid
coupled
magnetothermal
ablation
NDH-2-induced
reactive
oxygen
species
(ROS)
damage.
Our
study
demonstrates
is
ideal
platform
integrate
physical,
biological,
chemical
properties
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Oct. 24, 2022
Pore-forming
Gasdermin
protein-induced
pyroptosis
in
tumor
cells
promotes
anti-tumor
immune
response
through
the
release
of
pro-inflammatory
cytokines
and
immunogenic
substances
after
cell
rupture.
However,
endosomal
sorting
complexes
required
for
transport
(ESCRT)
III-mediated
membrane
repair
significantly
diminishes
by
repairing
subsequently
removing
gasdermin
pores.
Here,
we
show
that
blocking
calcium
influx-triggered
ESCRT
III-dependent
a
biodegradable
nanoparticle-mediated
sustained
chelator
(EI-NP)
strongly
enhances
intracellularly
delivered
GSDMD-induced
via
bacteria-based
delivery
system
(VNP-GD).
An
injectable
hydrogel
lyophilized
hydrogel-based
patch
are
developed
peritumoral
administration
treating
primary
metastatic
tumors,
implantation
inoperable
tumors
respectively.
The
hydrogels,
functioning
as
local
therapeutic
reservoirs,
can
sustainedly
VNP-GD
to
effectively
trigger
EI-NP
prevent
III-induced
plasma
boost
effects,
working
synergistically
augment
response.
ACS Nano,
Journal Year:
2023,
Volume and Issue:
17(5), P. 5059 - 5071
Published: Feb. 27, 2023
Photosensitizer-based
therapy
often
suffers
from
unitary
and
easily
attenuated
photosensitive
effects,
limited
tumor
penetration
retention,
requirement
of
multiple
irradiation
for
combination
therapy,
which
largely
restrict
its
application.
Here,
bacteria
are
integrated
with
a
monochromatic
irradiation-mediated
ternary
photosensitizers
photoacoustic
imaging-guided
synergistic
photothermal
therapy.
Bacteria
that
bioengineered
to
express
natural
melanin
decorated
dual
synthetic
by
nanodeposition
indocyanine
green
polydopamine
under
cytocompatible
condition.
The
combined
photosensitizers,
share
an
adequate
excitation
at
808
nm,
endow
stable
triple
effect
irradiation.
Due
their
living
characteristics,
these
preferentially
colonize
hypoxic
tissue
homogeneous
distribution
durable
retention
generate
uniform
imaging
signals
sufficient
heating
upon
laser
Supported
significantly
inhibited
growth
extended
survival
animals
in
different
tumor-bearing
murine
models,
our
work
proposes
the
development
bacteria-based
innovative